Drug-resistant hypertension is defined as suboptimal blood pressure control despite the treatment with at least three blood pressure-lowering drugs. Up until now, choosing a 4th add-on drug in these patients has been a doctor’s subjective preference more than a scientifically sound decision. Well, these times are over because Bryan Williams and colleagues found out what you should do in these patients in the so-called REVERT-2 trial, which was published in the Lancet in September 2015. Watch the above video to learn all about it.
What’s the next step?
If you want to become an expert on all things relating to diuretics, then check out our Fluids and Electrolytes Masterclass where we will teach you everything you need to know about this hot topic.
Be sure to download the free infographic at ➡️ [ Ссылка ]
Check out our ECG mastery program here ➡️ [ Ссылка ]
